For decades, cancer treatment has been stymied not by an inability to design lethal drugs, but by the body's own architecture — the dense fibrous tissue surrounding tumors that prevents medicine from ever reaching its target. Researchers publishing in Nature Communications have now described a platinum nanodrug coated in cholesterol that turns this barrier into a doorway, exploiting the fibroblasts' own molecular transport machinery to carry the drug through and deep into tumor tissue. The work reframes a fundamental problem in oncology: that reaching a tumor and penetrating it are two entirel